Application of plant lactobacillus LP45 in preparation of product for preventing or repairing gastric mucosal lesion

By using LP45 of Lactobacillus plantarum LP45 to inhibit Helicobacter pylori and promote mucin protein secretion, the side effects of chemical drugs and insufficient regulation of the gastric mucosa in the prior art were solved, and effective protection and repair of the gastric mucosa was achieved.

CN119015327APending Publication Date: 2024-11-26HEBEI YIRAN BIOLOGICAL TECH CO LTD
View PDF 7 Cites 0 Cited by

Patent Information

Application Number
CN202411115744.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-14
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

Most of the existing drugs used to protect and repair the gastric mucosa are chemical drugs. Long-term use can easily cause side effects, and the secretion of gastric mucus layer is regulated, especially promoting the secretion of factors such as MUC1, MUC5AC and MUC6, has not been effectively studied, and it is difficult to effectively prevent it. and repair gastric mucosa damage.

Method used

LP45 of plantarum LP45 is used as the active ingredient to reduce the inflammatory response by inhibiting the growth and colonization of Helicobacter pylori, and promote the secretion of mucin proteins such as MUC1, MUC5AC, and MUC6 to protect and repair the gastric mucosa.

Benefits of technology

LP45 of Plantago LP45 can not only inhibit the growth and colonization of Helicobacter pylori and reduce inflammatory responses, but also promote the secretion of mucin protein, protect the gastric mucosa, reduce the damage caused by external stimulation, and has the effect of repairing the gastric mucosa. It is suitable for prevention and Repair gastric mucosa damage caused by Helicobacter pylori, drugs, alcohol, etc.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure HDA0004993568380000011
    Figure HDA0004993568380000011
  • Figure HDA0004993568380000012
    Figure HDA0004993568380000012
  • Figure HDA0004993568380000021
    Figure HDA0004993568380000021
Patent Text Reader

Abstract

The invention relates to an application of phytobacterium plantarum LP45 in preparation of a product for preventing or repairing gastric mucosal lesion, and the phytobacterium plantarum LP45 is used as a first active component for preventing or repairing gastric mucosal lesion and resisting helicobacter pylori infection. A large number of probiotics are screened, and it is found that the plant lactobacillus LP45 can inhibit growth of helicobacter pylori, inhibit colonization of the helicobacter pylori in gastric cells, inhibit secretion of IL-8 mediated by the helicobacter pylori and relieve inflammatory response caused by the helicobacter pylori; in addition, secretion of mucous proteins such as MUC1, MUC5AC and MUC6 can be promoted, the gastric mucosa is protected, damage of various external stimulations to the gastric mucosa is reduced, and in addition, the effect of repairing the damaged gastric mucosa is achieved. The composition not only can be used for protecting and protecting gastric mucosa stimulated by helicobacter pylori, drugs and the like, but also can be applied to repair treatment of lost gastric mucosa.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of microbial application, and particularly relates to application of Lactobacillus plantarum LP45 in preparing a product for preventing or repairing gastric mucosal damage. Background Art

[0002] The gastric mucus layer is an insoluble gel layer attached to the epithelial layer of the gastric mucosa and the water-soluble viscous mucus in the cavity. These gels and mucus are secreted by the gastric epithelial cells and glands, and contain a large amount of mucus proteins, such as MUC1, MUC5AC and MUC6. These gels and mucus secretions can prevent the gastric mucosa from being exposed to various adverse factors, and can prevent gastric acid, pepsin and various harmful factors from damaging the gastric mucosa. In particular, MUC1 can interact with various factors on the extracellular side of the cell and participate in downstream signaling pathways to promote cell repair and survival.

[0003] In daily life, various mucosal damage factors, such as drugs, bile salts, ethanol, strong tea, coffee, Helicobacter pylori infection, etc., may damage the gastric mucosa. Among them, Helicobacter pylori can synthesize and secrete lipase protease, degrade the mucus layer of the gastric epithelium, and make it lose its protective properties. The protease secreted by it can depolymerize mucus protein polymers, and the secreted lipase, especially phospholipase A2, can degrade lipids in the mucus, eventually leading to the formation of lysophosphatidylcholine and the loss of the hydrophobic protective layer of the gastric mucosa. In addition, Helicobacter pylori can also inhibit the secretion of mucus cells, further promoting the loss of protection of the gastric epithelium.

[0004] Therefore, it is crucial to develop a drug that can promote the secretion of gastric mucus layer, protect gastric mucosa from damage by external adverse factors, especially promote the secretion of protein factors such as MUC1, MUC5AC and MUC6, and prevent and repair damaged gastric mucosa.

[0005] Currently, most drugs used to protect and repair gastric mucosa are chemical drugs, which can easily cause side effects if used for a long time. As for the protective effect of probiotics on gastric mucosa, current research mainly focuses on inhibiting the growth and attachment of Helicobacter pylori. However, there are no studies on the secretion regulation of the gastric mucus layer, especially on promoting gastric-specific factors such as MUC1, MUC5AC and MUC6. Summary of the invention

[0006] The purpose of the present invention is to overcome the defects in the prior art and provide the use of Lactobacillus plantarum LP45 in preparing a product for preventing or repairing gastric mucosal damage.

[0007] To achieve the above purpose, the technical solution adopted by the present invention is as follows:

[0008] The invention discloses an application of Lactobacillus plantarum LP45 in preparing a product for preventing or repairing gastric mucosal damage or preparing a product for resisting Helicobacter pylori infection.

[0009] As a further technical solution, the product includes one or more of microbial agents, food additives, feed additives, compositions, and pharmaceutical preparations.

[0010] As a further technical solution, the gastric mucosal damage is caused by mucosal damage factors such as alcohol, acetic acid, drugs, spicy stimulation, Helicobacter pylori infection, etc.

[0011] As a further technical solution, the anti-Helicobacter pylori infection includes one or more of inhibiting the growth of Helicobacter pylori, inhibiting the colonization of Helicobacter pylori in the stomach, and alleviating the inflammatory response mediated by Helicobacter pylori.

[0012] A composition of the Lactobacillus plantarum LP45, wherein the Lactobacillus plantarum LP45 is used as a first active ingredient and is used for preventing or repairing gastric mucosal damage.

[0013] As a further technical solution, the composition further comprises a second active ingredient.

[0014] As a further technical solution, the composition also includes a protective agent.

[0015] The protective agent includes one or more of trehalose, soy protein and whey protein.

[0016] Compared with the prior art, the present invention has the following beneficial effects:

[0017] The present invention screens a large number of probiotics, and finds that Lactobacillus plantarum LP45 can not only inhibit the growth of Helicobacter pylori, inhibit the colonization of Helicobacter pylori in gastric cells, inhibit the secretion of IL-8 mediated by Helicobacter pylori, and reduce the inflammatory response caused by Helicobacter pylori; it can also promote the secretion of mucus proteins such as MUC1, MUC5AC, and MUC6, protect gastric mucosa, reduce the damage of gastric mucosa to gastric mucosa by various external stimuli, and in addition, it also has a repairing effect on damaged gastric mucosa. It can not only be used for the protection and protection of gastric mucosa in various stimuli such as Helicobacter pylori, mucosal damage drugs, alcohol, and peppers, but also can be applied to the repair treatment of damaged gastric mucosa. BRIEF DESCRIPTION OF THE DRAWINGS

[0018] Figure 1 This is a diagram showing the inhibitory effect of the supernatant of Lactobacillus plantarum LP45 on Helicobacter pylori in Example 1 of the present invention;

[0019] Figure 2 This is a diagram showing the adhesion of Lactobacillus plantarum LP45 to gastric mucosal cells in Example 2 of the present invention;

[0020] Figure 3 This is a graph showing the competitive adhesion of Lactobacillus plantarum LP45 and Helicobacter pylori to gastric mucosal cells in Example 3 of the present invention;

[0021] Figure 4 This is a diagram showing the inhibitory effect of Lactobacillus plantarum LP45 on Helicobacter pylori-mediated IL-8 secretion in Example 4 of the present invention;

[0022] Figure 5 This is a diagram showing the regulating effect of Lactobacillus plantarum LP45 on the gastric mucus layer in Example 5 of the present invention;

[0023] Figure 6 This is a diagram showing the protective effect of Lactobacillus plantarum LP45 on gastric mucosal cell damage caused by various stimuli in Example 6 of the present invention;

[0024] Figure 7 This is a diagram showing the repair effect of Lactobacillus plantarum LP45 on gastric mucosal cell damage in Example 7 of the present invention.

[0025] exist Figure 7 Middle, a:AGS; b:AGS+LP45 DETAILED DESCRIPTION

[0026] The technical solution of the present invention will be clearly and completely described below in conjunction with specific embodiments. Obviously, the described embodiments are part of the embodiments of the present invention, rather than all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0027] In addition, it should be noted that the terms "comprises", "includes" or any other variations thereof are intended to cover non-exclusive inclusion, so that a process, method, article or apparatus that includes a series of elements includes not only those elements, but also other elements not explicitly listed, or also includes elements inherent to such process, method, article or apparatus.

[0028] In the present invention, the deposit number of Lactobacillus plantarum LP45 is CGMCC No.8072, which is disclosed in the patent application with application number CN201310587738.8 and invention name “A Lactobacillus plantarum and its application”;

[0029] Unless otherwise specified, the raw materials used in the present invention are all commercially available.

[0030] Example 1: Inhibitory effect of Lactobacillus plantarum LP45 supernatant on Helicobacter pylori

[0031] 1. Test methods and results

[0032] First, Columbia blood agar plates were prepared, the concentration of Helicobacter pylori just after activation was adjusted and evenly coated on the blood agar plates, and then MRS liquid culture medium was used as a negative control; after activating and culturing Lactobacillus plantarum LP45 for three consecutive generations, the bacterial solution was centrifuged at 8000g for 10 minutes and then filtered through a 0.22μm sterile filter membrane to obtain Lactobacillus plantarum LP45 supernatant; the inhibitory effect of the supernatant on Helicobacter pylori was determined by the Oxford cup method, and the microanaerobic culture was performed for 24-48 hours. The results are shown in Table 1. Figure 1 .

[0033] 2. Results and Analysis

[0034] from Figure 1 It can be seen that the diameter of the inhibition zone of MRS is 10.5±1.2mm, and the diameter of the inhibition zone of the supernatant of Lactobacillus plantarum LP45 is 14.5±1.9mm; the supernatant of Lactobacillus plantarum LP45 showed a significant inhibitory effect on the growth of Helicobacter pylori, which may be due to the fact that the metabolites of Lactobacillus plantarum LP45 contain organic acids (such as lactic acid), bacteriocins and other substances, among which lactic acid can change the permeability of the cell membrane of Gram-negative bacteria, thereby enhancing the antibacterial effect, and the lactic acid content is positively correlated with the degree of inhibition of Helicobacter pylori. Therefore, the supernatant of Lactobacillus plantarum LP45 showed a significant inhibitory effect on the growth of Helicobacter pylori.

[0035] Example 2: Adhesion effect of Lactobacillus plantarum LP45 on gastric mucosal cells

[0036] 1. Test methods

[0037] The adherent AGS cells that had been cultured stably for three consecutive generations were digested with trypsin to terminate the reaction, and then centrifuged and washed, and suspended in F12 basal medium without resistance and serum to adjust the cell fluid concentration to 5×10 4 / ml, add coverslips, wait until the cells cover the plate, add Lactobacillus plantarum LP45, and culture for 3 hours; wash the slides 3 times with PBS buffer, fix with methanol fixative for 2 hours, wash and dry, and then examine under a microscope after Gram staining. Figure 2 .

[0038] 2. Results and Analysis

[0039] from Figure 2 It can be seen that there is a strong adhesion between Lactobacillus plantarum LP45 bacteria and gastric mucosal cells (AGS cells), and they can adhere tightly around AGS cells. The strong adhesion ability of Lactobacillus plantarum LP45 to AGS cells indicates that it has a strong colonization potential in the stomach, providing the possibility for it to play a probiotic function in the stomach.

[0040] Example 3: Lactobacillus plantarum LP45 can inhibit the adhesion of Helicobacter pylori to gastric mucosal cells

[0041] 1. Test methods

[0042] The adherent AGS cells that had been stably cultured for three consecutive generations were digested with trypsin to terminate the reaction, and then centrifuged and washed and suspended in F12 basal culture medium without resistance to adjust the cell solution concentration to 5×10 4 / ml, add serum, and wait until the cells are spread all over the plate. Add Helicobacter pylori, then add Lactobacillus plantarum LP45 for culture, and then wash three times with PBS; then add 100μL urease test solution, shake and measure the absorbance value with a 550nm microplate reader, and make a Helicobacter pylori control (only add Helicobacter pylori, no Lactobacillus plantarum LP45), the results are shown in Figure 3 .

[0043] 2. Results and Analysis

[0044] As a pathogen, Helicobacter pylori colonization in the stomach can cause a series of diseases, ranging from Figure 3 It can be seen that the absorbance value of Lactobacillus plantarum LP45 is significantly lower than that of Helicobacter pylori, and the higher the absorbance value, the more Helicobacter pylori are adhered and the worse the competition effect. Therefore, it can be seen that Lactobacillus plantarum LP45 can inhibit the adhesion of Helicobacter pylori to gastric epithelial cells through adhesive colonization; Lactobacillus plantarum LP45 has the potential to colonize in the stomach, can compete with Helicobacter pylori for adhesion sites on cells and inhibit the number of Helicobacter pylori.

[0045] Example 4: Lactobacillus plantarum LP45 inhibits Helicobacter pylori-mediated IL-8 secretion

[0046] 1. Test methods

[0047] The activated AGS cells were seeded in 24-well plates (seeding concentration was 5×10 4 / mL, culture volume 200μL) until the plate is fully covered, and the dead AGS cells are washed away with culture medium. Divided into three groups, group 1: culture medium; group 2: inoculated with Helicobacter pylori (Hp); group 3: inoculated with Hp first and then added with Lactobacillus plantarum LP45 cells; collect cells, centrifuge the culture solution at 8000g for 10min, collect the precipitate, extract RNA, measure the purity and concentration of nucleic acid, and reverse it into cDNA, perform qPCR test, and determine the transcription level of IL-8.

[0048] Among them, the primers used to amplify the target gene for detecting the transcription level of IL-8 are:

[0049] IL-8F: 5′-CCAGGAAGAAAACCACCGGAAG-3′;

[0050] IL-8R: 5′-TGGCAAAACTGCACCTTCACA-3′.

[0051] The primers used to amplify the internal reference gene for detecting the transcription level of IL-8 are:

[0052] β-actin-F: 5′-AGCGAGCATCCCCAAAGTT-3′;

[0053] β-actin-R: 5′-GGGCACGAAGGCTCATCATT-3′.

[0054] Take 0.8 μL of each upstream and downstream primers, 10 μL of 2×SYBR Green, 2 μL of cDNA template, and 6.0 μL of DEPC water to prepare a 20 μL PCR system. The amplification conditions are 95°C, 1 min pre-denaturation, 15 s denaturation at the same temperature, 58°C, 20 s annealing, 72°C extension 25 s, and 40 cycles. Select the internal reference gene and calculate the 2-△△Ct value based on the Ct value;

[0055] Among them, 2 -△△Ct Value = 2 -[(试验组Cq-内参组Cq)-(对照组Cq-内参组Cq)]

[0056] Assuming the transcription level of the AGS group is 1, the 2-△△Ct value of each experimental group divided by the 2-△△Ct value of the AGS group is the relative transcription level of IL-8 in each experimental group. The results are shown in Figure 4 ;

[0057] 2. Results and Analysis

[0058] After Helicobacter pylori infects the human body, it can stimulate gastric mucosal epithelial cells to produce a variety of cytokines, which will increase the production of IL-8, induce and promote a series of inflammatory reactions. Therefore, the present invention uses the transcription level of IL-8 to characterize the inhibitory effect of Lactobacillus plantarum LP45 on gastric inflammation caused by Helicobacter pylori;

[0059] Depend on Figure 4 It can be seen that the IL-8 transcription level of the AGS+Hp+LP45 group supplemented with Lactobacillus plantarum LP45 was significantly lower than that of the AGS+Hp group without Lactobacillus plantarum LP45. Therefore, it can be seen that Lactobacillus plantarum LP45 can inhibit the transcription level of the proinflammatory factor IL-8 and inhibit gastric inflammation caused by Helicobacter pylori infection.

[0060] Example 5: Regulatory effect of Lactobacillus plantarum LP45 on gastric mucus layer

[0061] 1. Test methods

[0062] The activated AGS cells were seeded in 24-well plates (seeding concentration was 5×10 4The cells were co-cultured with 100 μL of 1% paraformaldehyde (p / mL, culture volume 200 μL) for 24 h, and the dead AGS cells were washed away with culture medium. The cells were divided into three groups: group 1: culture medium; group 2: bacterial cells. The culture medium was collected, centrifuged at 8000 g for 10 min, the precipitate was collected, RNA was extracted, the purity and concentration of nucleic acid were measured, and it was reversed into cDNA for qPCR test. The transcription levels of mucins MUC1, MUC5AC, and MUC6 were calculated.

[0063] The primers used to amplify the target gene for detecting the transcription level of mucin are:

[0064] muc1F: 5′-CCTCCCCACCCATTTCACCA-3′;

[0065] muc1R: 5′-AACCTGAAGCTGGTTCCGTG-3′;

[0066] muc5acF: 5′-CTCCCACCCATCTGCTACAA-3′;

[0067] muc5acR: 5′-TGTGGTGAAGGTGGTCTGGG-3′;

[0068] Muc6F: 5′-GCATGGCGAACGTGACGGTAA-3′;

[0069] muc6R: 5′-TAGTCTGAGCCCCTGCTTGGCA-3′.

[0070] The primers used to amplify the internal reference gene for detecting the transcription level of mucin are:

[0071] β-actin-F: 5′-AGCGAGCATCCCCAAAGTT-3′;

[0072] β-actin-R: 5′-GGGCACGAAGGCTCATCATT-3′.

[0073] Take 0.8 μL of each upstream and downstream primers, 10 μL of 2×SYBR Green, 2 μL of cDNA template, and 6.0 μL of DEPC water to prepare a 20 μL PCR system. The amplification conditions are 95°C, 1 min pre-denaturation, 15 s denaturation at the same temperature, 58°C, 20 s annealing, 72°C extension 25 s, and 40 cycles. Select the internal reference gene and calculate the 2-△△Ct value based on the Ct value.

[0074] 2 -△△Ct Value = 2 -[(试验组Cq-内参组Cq)-(对照组Cq-内参组Cq)]

[0075] Assuming the transcription level of the AGS group was 1, the 2-△△Ct value of each experimental group divided by the 2-△△Ct value of the AGS group was the relative transcription level of mucins MUC1, MUC5AC, and MUC6 in each experimental group. The results are shown in Figure 5 ;

[0076] 2. Results and Analysis

[0077] The high molecular weight glycoprotein (mucin) secreted by gastric epithelial cells and glands forms the gastric mucus layer, which protects the gastric mucosa from being eroded and damaged by damaging factors such as gastric acid, proteolytic enzymes and inflammatory mediators. It is composed of a large amount of gel mucus and bicarbonate, so it is also called the mucus-bicarbonate barrier (mucus-bicarbonate barrier), and its components also include protein factors such as MUC1, MUC5AC, and MUC6.

[0078] Depend on Figure 5 It can be seen that the transcription levels of MUC1, MUC5AC, and MUC6 in the ACS+LP45 group with added Lactobacillus plantarum LP45 were significantly increased compared with the ACS control group without added Lactobacillus plantarum LP45. Therefore, it can be seen that Lactobacillus plantarum LP45 can increase the transcription levels of MUC1, MUC5AC, and MUC6, supplement the mucin in the mucus layer, ensure the thickness of the mucus layer, and improve the integrity of the mucus layer.

[0079] In addition, the secretion of mucins such as MUC1 also promotes the repair of gastric mucosa.

[0080] Example 6: Protective effect of Lactobacillus plantarum LP45 on gastric mucosal cells

[0081] 1. Test methods

[0082] Preparation of cell suspension: cell counting

[0083] S1. Inoculate into 96-well plate: According to the appropriate number of cells to be plated, about 100 μL of AGS cell suspension is added to each well. The same sample can be replicated 6 times.

[0084] S2. Culture in a cell culture incubator: wait until the cells fill the plate.

[0085] S3. Add LP45 supernatant, centrifuge and filter the bacteria for co-cultivation.

[0086] S4. Culture in a 37°C incubator: Add mucosal injury reagents (ethanol, acetic acid, aspirin, and capsaicin) and continue cell co-culture.

[0087] S5. Add 10ul CCK8, mix well and continue culturing.

[0088] S6. After the incubation, measure the absorbance at 450 nm; calculate the activity of the mucosal cells. The results are shown in Figure 6 ;

[0089] 2. Results and Analysis

[0090] Depend on Figure 6 It can be seen that the activity of mucosal cells in the LP45 group with added Lactobacillus plantarum LP45 was significantly improved compared with the mucosal injury reagent groups (ethanol group, acetic acid group, aspirin group, capsaicin group) without added Lactobacillus plantarum LP45. It can be seen that Lactobacillus plantarum LP45 can enhance the activity of gastric mucosal cells and reduce the damage to gastric mucosal cells caused by various external stimuli, such as external spicy stimulation, drug stimulation, alcohol stimulation, acid stimulation, etc.

[0091] Example 7: Effect of Lactobacillus plantarum LP45 in promoting the repair of damaged gastric mucosal cells

[0092] 1. Test methods

[0093] S1. Plate: After AGS cells are completely digested, add complete culture medium (Wuhan Punocell, AGS-specific cell culture medium) to stop digestion, thoroughly blow the cells evenly, and then plate them according to the proportion. If they are uneven, you can gently tap one horizontal side and one vertical side with your palm, and avoid tapping all four sides, otherwise the cells will easily gather in the middle.

[0094] S2. Understand the status of the cells, it is best if they can grow fully overnight.

[0095] S3. The next day, use the yellow gun tip to measure against a ruler (or gun tip, plate cover), and vertically scratch in the original culture medium, one line per well (you can also make more lines, referring to the cell status). The gun tip must be vertical and not tilted.

[0096] S4. Wash the cells 1-2 times with PBS buffer solution, remove the scratched cells, add low-serum culture medium (or complete culture medium); then take pictures under a microscope, using both high-power and low-power microscopes as much as possible.

[0097] S5. Add the supernatant of Lactobacillus plantarum LP45, centrifuge and filter the cells, place in an incubator at 37 degrees Celsius and 5% CO2, and culture for 24 hours. Figure 7 .

[0098] 2. Results and Analysis

[0099] Depend on Figure 7It can be seen that in the AGS group, the distances between AGS cell damage measured at any three locations were 772.74μm, 804.43μm, and 820.66μm, respectively, with an average value of 799.28±19.90μm; while in the AGS+LP45 group, the distances between AGS cell damage measured at any three locations were 711.15μm, 657.68μm, and 739.68μm, respectively, with an average value of 702.84±33.99μm; in the AGS+LP45 group with added Lactobacillus plantarum LP45, the distance between cell damage was significantly reduced compared with that in the AGS group without added Lactobacillus plantarum LP45. Therefore, it can be seen that the addition of Lactobacillus plantarum LP45 can play a role in repairing gastric mucosal damage.

[0100] The above-described embodiments are only preferred embodiments of the present invention, and are not exhaustive of the feasible implementations of the present invention. For those skilled in the art, any obvious changes made thereto without departing from the principles and spirit of the present invention should be considered to be included in the scope of protection of the claims of the present invention.

Claims

1. Use of Lactobacillus plantarum LP45 in preparing a product for preventing or repairing gastric mucosal damage or preparing a product for resisting Helicobacter pylori infection.

2. The use according to claim 1, characterized in that: The product includes one or more of microbial agents, food additives, feed additives, compositions, and pharmaceutical preparations.

3. The use according to claim 1, characterized in that: The gastric mucosal damage is caused by any one of alcohol, acetic acid, drugs, Helicobacter pylori infection, and spicy stimulation.

4. The use according to claim 1, characterized in that: The anti-Helicobacter pylori infection comprises one or more of inhibiting the growth of Helicobacter pylori, inhibiting the colonization of Helicobacter pylori in the stomach, and alleviating the inflammatory response mediated by Helicobacter pylori.

5. A composition comprising the Lactobacillus plantarum LP45 of claim 1, characterized in that: Lactobacillus plantarum LP45 is used as the first active ingredient to prevent or repair gastric mucosal damage.

6. The composition according to claim 5, characterized in that The composition also includes a second active ingredient.

7. The composition according to claim 5, characterized in that The composition further comprises one or more of a stabilizer and a protective agent.

Citation Information

Patent Citations

  • Applications of lactobacillus plantarum S58 in preparation of products for relieving damage of spicy food to digestive system

    CN111035662A

  • Lactic acid bacteria for preventing and treating gastritis caused by helicobacter pylori and application of lactic acid bacteria

    CN112080444A

  • Lactobacillus rhamnosus LR863 and lactobacillus rhamnosus LR519 for synergistically inhibiting helicobacter pylori and application of lactobacillus rhamnosus LR863 and lactobacillus rhamnosus LR519

    CN112746034A

  • Lactobacillus plantarum LP1Z capable of producing lysozyme and efficiently antagonizing multidrug-resistant helicobacter pylori and application of lactobacillus plantarum LP1Z

    CN114350578A

  • Lactobacillus plantarum and application thereof

    CN114774326A